Dan Barton

Forian Inc. (NASDAQ: FORA) released financial results for the quarter ended September 30, 2022, revealing revenue of $7.2 million, a 45% increase compared to $5 million in the Q3 2021 and 10% sequentially over the second quarter of 2022. Q3 2022 Financial Highlights Net loss for the quarter was $...

Forian Inc. (NASDAQ: FORA) released results for the quarter ended June 30, 2022. Q2 2022 Financial Highlights Revenue for the quarter was $6.5 million, an increase of 44% versus the prior year and 2% sequentially over the first quarter of 2022. Net loss for the quarter was $5.4 million, or $0...

Forian Inc. (NASDAQ: FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, announced financial results for the quarter and year ended December 31, 2021. “We have achieved many milestones in the last year,” said Max...

Forian Inc. (NASDAQ: FORA), a provider of technology, analytics and science-driven data solutions for the healthcare and cannabis industries, announced its financial results for the fiscal quarter ended September 30, 2021. Third Quarter 2021 Financial Results Revenue for the quarter was...

Psychedelics-focused medicines company Mind Medicine Inc. (NASDAQ: MNMD), (NEO: MMED) announced Tuesday that it has teamed up with Forian Inc. (NASDAQ: FORA), a provider of evidence-based support for more comprehensive clinical and commercial decision-making. MindMed and Forian will collaborate to...